Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole versus famotidine after lumbar spine fusion surgery
IRCT20140915019185N4Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in lumbar spondylosis, lumbar spinal stenosis (LSS), spondylolisthesis and 2 more comparing Pantoprazole with Famotidine (2 arms). Primary endpoint: Bone fusion. Started Sep 2020; status: completed.
02
Drugs
pantoprazolefamotidine
03
Conditions
lumbar spondylosislumbar spinal stenosis (LSS)spondylolisthesisdegenerative disc disease (DDD)spinal deformities
Beyond the preview
Go deeper on IRCT20140915019185N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140915019185N4.